Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
6.54B
BB
72.73B
BBB
52.45B
AA
46.63B
BBB
42.13B
A
28.56B
AA
21.57B -
BBB
- -
19.95B
AAA
19.69B
AA
16.32B
AA
13.2B -
BB
- -
12.47B
CCC
11.19B -
BBB
- -
10.45B
BBB
-
9.01B -
B
- -
7.96B -
BB
- - -
7.13B
A
6.52B - - - - -
6.23B -
B
- - - - -
5.48B -
A
- - -
Average 20.81B
A
Weighted average by Cap.
A
Biopharmaceuticals